You signed in with another tab or window. Reload to refresh your session.You signed out in another tab or window. Reload to refresh your session.You switched accounts on another tab or window. Reload to refresh your session.Dismiss alert
Whole cell models could be adapted to work in drug discovery contexts, but it might be easier to start with building these whole cell model frameworks for disease causing agents (for example Mycoplasmas Tuberculosis), before we go to tumor cell lines and the like.
Whole Cell Modelling so far, looks to have been applied to organisms that have been well studied and those which have a lesser number of components. For tumor cell lines, getting the right data is harder, the cellular system is much more complex and there is much yet to be discovered.
Whole cell models are a very promising avenue of work in systems biology. Can whole cells models be adapted to work in drug discovery contexts?
Relevant papers:
Weaknesses in current work:
The text was updated successfully, but these errors were encountered: